As September marks the beginning of Blood Cancer Awareness Month, delve into what is being developed in the biotech pipelines. The post Blood Cancer Awareness Month: What biotech holds in store appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to ...| Labiotech.eu
Find out about ExCellThera's zemcelpro, the first blood cord expansion therapy to reach the European market, and only the second globally. The post Zemcelpro, the first blood cord expansion therapy to reach the EU market appeared first on Labiotech.eu. © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full an...| Labiotech.eu
Christine Graham was pregnant with her first child when she made a decision that would save a life. She agreed to donate her umbilical cord blood, making it available to a stranger who needed a stem cell transplant. “I don’t think I’ll fully grasp what that has done for someone,” said Graham. “I try to…| Kaiser Permanente Look insideKP Northern California
The oral liquid can treat specific forms of acute lymphoblastic leukemia and chronic myeloid leukemia, and other cancers, including rare ones.| Rare Cancer News
Based on a clinical trial, the CAR T-cell therapy was approved for relapsed or refractory precursor B-cell acute lymphoblastic leukemia.| Rare Cancer News